BKNG
Booking Holdings Inc.
BKNG has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
BKNG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Healthy |
BKNG's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BKNG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $161 | — |
| Current | 17x | $161 | — |
| Cheap | 23x | $212 | +32% |
| Fair | 32x | $294 | +82% |
| Expensive | 128x | $1,188 | +637% |
Historical ranges are pointers, not guarantees.
BKNG's PE is in its cheap range at 17x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BKNG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for BKNG, with profitability improving.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BKNG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.78 | +27% |
| Q3 2026 | $9.25 | +51% |
| Q2 2026 | $9.01 | +57% |
| Q1 2026 | $7.58 | +18% |
| Q4 2025 | $6.62 | -4.2% |
| Q3 2025 | $6.14 | +4.6% |
| Q2 2025 | $5.74 | +0.9% |
| Q1 2025 | $6.42 | +21% |
| Q4 2024 | $6.91 | +47% |
BKNG has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BKNG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.9B | -1.3% |
| Q2 2026 | $7.4B | +8.1% |
| Q1 2026 | $5.5B | +16% |
| Q4 2025 | $6.3B | +16% |
| Q3 2025 | $9B | +13% |
| Q2 2025 | $6.8B | +16% |
| Q1 2025 | $4.8B | +7.9% |
| Q4 2024 | $5.5B | +14% |
BKNG's revenue is growing: $8.9B last quarter, down 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | -0.2 points |
| Q2 2026 | 34% | +0.9 points |
| Q1 2026 | 23% | +0.7 points |
| Q4 2025 | 32% | +0.4 points |
| Q3 2025 | 39% | -1.1 points |
| Q2 2025 | 33% | +1.4 points |
| Q1 2025 | 22% | +4.4 points |
| Q4 2024 | 32% | +19 points |
BKNG has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BKNG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BKNG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | -22% |
| Q2 2026 | $3.6B | +16% |
| Q1 2026 | $3.1B | -1.7% |
| Q4 2025 | $1.4B | +120% |
| Q3 2025 | $1.4B | -40% |
| Q2 2025 | $3.1B | +32% |
| Q1 2025 | $3.2B | +23% |
| Q4 2024 | $645M | -48% |
BKNG has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BKNG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.2% | -17M shares |
| 1 year | -7.5% | -61M shares |
| 3 years | -16% | -147M shares |
| 5 years | -27% | -281M shares |
| Available history | -31% | -335M shares |
BKNG has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.1B |
| Q2 2026 | $4B |
| Q1 2026 | $3.8B |
| Q4 2025 | $2.1B |
| Q3 2025 | $653M |
| Q2 2025 | $1.5B |
| Q1 2025 | $2.2B |
| Q4 2024 | $1.2B |
BKNG spent $12B buying back its own shares over the past year, up 117% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BKNG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.1x | Very low |
BKNG's net debt is less than a year of its operating earnings (EBITDA).
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BKNG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 14.6 | Oversold |
BKNG's weekly RSI is 43 (neutral) and its Stochastic is 15 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BKNG PE vs Consumer Cyclical Sector
| Metric | BKNG | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 3.3% below |
| PE % | 4 | 47 | 43 pts below |
BKNG is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BKNG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 1.3% above |
| 20 week MA | $178.2 | 9.5% below |
| 50 week MA | $180.8 | 11% below |
| 100 week MA | $193.2 | 17% below |
| 200 week MA | $164.3 | 1.9% below |
BKNG has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BKNG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $82.9 | $83.5 | +0.8% |
| 2021 | $83.5 | $96.1 | +15% |
| 2022 | $96.1 | $78.9 | -18% |
| 2023 | $78.9 | $141.9 | +80% |
| 2024 | $141.9 | $201.5 | +42% |
| 2025 | $201.5 | $217.6 | +8% |
| 2026 YTD | $217.6 | $161.2 | -26% |
BKNG has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.